• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与2型糖尿病之间的双向关系:一项基于人群的前瞻性队列研究。

The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study.

作者信息

Wang Minzhen, Zhao Yanan, He Yingqian, Zhang Lulu, Liu Jing, Zheng Shan, Bai Yana

机构信息

Department of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, Gansu, China.

Department of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, Gansu, China.

出版信息

Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1521-1528. doi: 10.1016/j.numecd.2023.05.018. Epub 2023 May 17.

DOI:10.1016/j.numecd.2023.05.018
PMID:37336719
Abstract

BACKGROUND AND AIMS

To explore the bidirectional relationship between NAFLD and type 2 diabetes and the possible directions of the main effect.

METHODS AND RESULTS

30 633 participants from the Jinchang cohort were enrolled. Firstly, cox proportional hazards regression model was used to assess the unidirectional causality between NAFLD and prediabetes and type 2 diabetes. Secondly, cross-lag path analysis model was conducted to estimate the bidirectional relationship between NAFLD and prediabetes and type 2 diabetes, and to determine the direction of the main effects. Finally, potential effect modifications were also considered by age, sex, hyperlipidemia, and overweight/obesity. We found that NAFLD increased the risk of prediabetes and type 2 diabetes with adjusted HR (95%CI) of 1.355(95%CI: 1.255-1.462) and 1.898(95%CI: 1.415-2.545), respectively. Prediabetes and type 2 diabetes also increased the risk of NAFLD, with adjusted HR (95%CI) of 1.245(95%CI: 1.115-1.392) and 1.592(95%CI: 1.373-1.846), respectively. Cross-lag path analysis showed that NAFLD significantly affected the incidence of prediabetes (β = 0.285, P < 0.001), while the effect on type 2 diabetes was not statistically significant. The effect of prediabetes and type 2 diabetes on the risk of NAFLD was weak, and the path coefficients were 0.076 and 0.037, respectively. Stratified analyses showed similar results.

CONCLUSION

This study provides evidence that there was a bidirectional causal association between NAFLD and type 2 diabetes, and the progression from NAFLD through prediabetes to type 2 diabetes may be the main pathway.

摘要

背景与目的

探讨非酒精性脂肪性肝病(NAFLD)与2型糖尿病之间的双向关系以及主要效应的可能方向。

方法与结果

纳入金昌队列的30633名参与者。首先,采用Cox比例风险回归模型评估NAFLD与糖尿病前期及2型糖尿病之间的单向因果关系。其次,进行交叉滞后路径分析模型,以估计NAFLD与糖尿病前期及2型糖尿病之间的双向关系,并确定主要效应的方向。最后,还考虑了年龄、性别、高脂血症和超重/肥胖等潜在效应修饰因素。我们发现,NAFLD增加了糖尿病前期和2型糖尿病的风险,校正后的风险比(95%置信区间)分别为1.355(95%置信区间:1.255 - 1.462)和1.898(95%置信区间:1.415 - 2.545)。糖尿病前期和2型糖尿病也增加了NAFLD的风险,校正后的风险比(95%置信区间)分别为1.245(95%置信区间:1.115 - 1.392)和1.592(95%置信区间:1.373 - 1.846)。交叉滞后路径分析表明,NAFLD显著影响糖尿病前期的发病率(β = 0.285,P < 0.001),而对2型糖尿病的影响无统计学意义。糖尿病前期和2型糖尿病对NAFLD风险的影响较弱,路径系数分别为0.076和0.037。分层分析显示了相似的结果。

结论

本研究提供了证据表明NAFLD与2型糖尿病之间存在双向因果关联,并且从NAFLD经糖尿病前期进展至2型糖尿病可能是主要途径。

相似文献

1
The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study.非酒精性脂肪性肝病与2型糖尿病之间的双向关系:一项基于人群的前瞻性队列研究。
Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1521-1528. doi: 10.1016/j.numecd.2023.05.018. Epub 2023 May 17.
2
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
3
Prediabetes transitions to normoglycaemia or type 2 diabetes and associated risk factors in the Obesity, Diabetes and Cardiovascular Disease Collaboration: an individual-level pooled analysis of 19 prospective cohort studies.肥胖、糖尿病和心血管疾病协作组中糖尿病前期向正常血糖或2型糖尿病的转变及相关危险因素:19项前瞻性队列研究的个体水平汇总分析
Lancet Glob Health. 2025 Sep;13(9):e1533-e1542. doi: 10.1016/S2214-109X(25)00237-2.
4
Predictive value of MetS-IR for the glucose status conversion in prediabetes: a multi-center retrospective cohort study.代谢综合征胰岛素抵抗(MetS-IR)对糖尿病前期血糖状态转换的预测价值:一项多中心回顾性队列研究。
BMC Endocr Disord. 2025 Jul 1;25(1):162. doi: 10.1186/s12902-025-01974-5.
5
Association of weight status and the risks of diabetes in adults: a systematic review and meta-analysis of prospective cohort studies.体重状况与成年人糖尿病风险的关联:前瞻性队列研究的系统评价和荟萃分析。
Int J Obes (Lond). 2022 Jun;46(6):1101-1113. doi: 10.1038/s41366-022-01096-1. Epub 2022 Feb 23.
6
Multi-dimensional characterization of prediabetes in the Project Baseline Health Study.项目基线健康研究中糖尿病前期的多维特征。
Cardiovasc Diabetol. 2022 Jul 18;21(1):134. doi: 10.1186/s12933-022-01565-x.
7
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
8
The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.糖尿病患者与非糖尿病患者以及代谢功能障碍相关脂肪性肝病患者中晚期肝纤维化的患病率及其相关因素:一项横断面研究。
J Diabetes Complications. 2025 Aug 6;39(10):109147. doi: 10.1016/j.jdiacomp.2025.109147.
9
Mediating effect of diabetes on the relationship between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease: a prospective cohort study.糖尿病在非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病关系中的中介作用:一项前瞻性队列研究。
Eur J Gastroenterol Hepatol. 2024 Sep 1;36(9):1133-1140. doi: 10.1097/MEG.0000000000002794. Epub 2024 May 20.
10
The impact of prediabetes and diabetes on endothelial function in a large population-based cohort.在一个大型基于人群的队列中,前驱糖尿病和糖尿病对血管内皮功能的影响。
Blood Press. 2024 Dec;33(1):2298309. doi: 10.1080/08037051.2023.2298309. Epub 2024 Jan 7.

引用本文的文献

1
U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study.非酒精性脂肪性肝病患者全因死亡率和心血管死亡率的应激性高血糖比值呈U形关联:来自美国国家健康与营养检查调查(NHANES)数据库前瞻性队列研究的结果
BMC Gastroenterol. 2025 Jul 1;25(1):477. doi: 10.1186/s12876-025-04082-9.
2
Investigating the Mechanisms of in Treating Nonalcoholic Fatty Liver Disease and Diabetes Comorbidity Through Network Pharmacology and Molecular Dynamics.基于网络药理学和分子动力学探究[具体药物或疗法名称缺失]治疗非酒精性脂肪性肝病和糖尿病合并症的机制
Food Sci Nutr. 2025 May 26;13(6):e70256. doi: 10.1002/fsn3.70256. eCollection 2025 Jun.
3
Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD.
代谢综合征与肝脏疾病:从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病范式转变下的筛查、诊断及治疗再评估
J Clin Med. 2025 Apr 16;14(8):2750. doi: 10.3390/jcm14082750.
4
Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.达格列净通过抑制脂质蓄积、炎症反应和肝纤维化来减轻代谢功能障碍相关脂肪性肝病。
BMC Pharmacol Toxicol. 2025 Mar 12;26(1):59. doi: 10.1186/s40360-025-00898-z.
5
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.胰高血糖素样肽-1受体激动剂治疗代谢功能障碍相关脂肪性肝病患者的疗效与安全性:一项随机对照试验的系统评价和荟萃分析
Cureus. 2024 Oct 13;16(10):e71366. doi: 10.7759/cureus.71366. eCollection 2024 Oct.
6
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives.在管理 2 型糖尿病患者时不应忽视的问题:肾脏病学和肝脏病学视角。
Int J Mol Sci. 2024 Jul 15;25(14):7728. doi: 10.3390/ijms25147728.